Until the end of March, Novo Nordisk will let people with prescriptions buy the first two doses of the drugs for $199 a month ...

Liver fibrosis is a growing global concern, driven by chronic conditions like hepatitis, obesity, and alcohol use. This progressive liver disease, marked by scar tissue buildup, can advance to ...

The Hemophilia B market is growing rapidly due to advancements in gene therapy and diagnostics. This rare genetic disorder, caused by F9 gene mutations, primarily affects males. Revolutionary ...

Hemophilia A, a rare genetic disorder marked by a deficiency of clotting factor VIII, leads to prolonged bleeding and joint damage. Enhanced treatment options, like extended half-life clotting factors ...

Alzheimer's disease (AD) is a devastating cause of memory loss and cognitive decline, for which no curative treatment is available.

"The Court ultimately concludes that the agency has not carried its burden: Meta holds no monopoly in the relevant market," U ...

"The Court ultimately concludes that the agency has not carried its burden: Meta holds no monopoly in the relevant market," U ...

According to DataM Intelligence, Metabolic Disorders Therapeutics Market Size was valued at US$74.97 billion in 2024 and is forecast to nearly double to US$157.65 billion by 2033, reflecting a ...

Oral semaglutide delivered meaningful reductions in HbA1c and body weight among GLP-1RA-naïve adults with type 2 diabetes in ...

DelveInsight's Osteoporosis Market Insights report includes a comprehensive understanding of current treatment practices, ...